MPRILA 30 MG 10 TABLETS | Apremilast PDE4 Inhibitor Medicine
MPRILA 30 MG 10 TABLETS contain Apremilast 30 mg, a prescription phosphodiesterase-4 (PDE4) inhibitor used for the management of plaque psoriasis, psoriatic arthritis, and Behçet's disease-associated oral ulcers.
MPRILA 30 MG 10 TABLETS
MPRILA 30 MG TABLETS (Apremilast 30 mg): Comprehensive Guide and Benefits
Introduction to MPRILA 30 MG TABLETS
PDE4 Inhibitor for Chronic Inflammatory Conditions
MPRILA 30 MG 10 TABLETS contain Apremilast 30 mg, a prescription Phosphodiesterase-4 (PDE4) inhibitor. It is used for the management of moderate to severe plaque psoriasis, active psoriatic arthritis, and oral ulcers associated with Behçet's disease. Apremilast works by regulating inflammatory pathways involved in chronic immune-mediated disorders.
Prescription Status: Prescription-only medicine. Use only under the supervision of a qualified healthcare professional.
Key Benefits of MPRILA 30 MG TABLETS
Helps regulate inflammation associated with immune-mediated diseases.
Oral treatment option for eligible patients.
Targets the PDE4 enzyme involved in inflammatory processes.
Suitable for long-term treatment under medical supervision.
Supports comprehensive disease management as part of an individualized treatment plan.
Composition
Active Ingredient:
Apremilast – 30 mg
Dosage Form:
Tablet
Pack Size:
10 Tablets
Drug Class
Phosphodiesterase-4 (PDE4) Inhibitor
Immunomodulatory Agent
Therapeutic Category
Immunomodulatory Medicine
Anti-Inflammatory Medicine
How MPRILA 30 MG Works
Apremilast selectively inhibits the PDE4 enzyme inside immune cells. This increases intracellular cyclic AMP (cAMP) levels, helping regulate inflammatory mediators and reducing excessive immune activity associated with chronic inflammatory diseases.
Usage Instructions
Take MPRILA 30 MG TABLETS exactly as prescribed by your doctor.
Swallow the tablet whole with water.
It may be taken with or without food.
Take the medicine at the same time each day.
Continue treatment for the full duration recommended by your healthcare provider.
Medicinal Advantages
Targeted Immune Regulation
Helps regulate inflammatory pathways by selectively inhibiting the PDE4 enzyme.
Convenient Oral Therapy
Provides an effective oral treatment option without injections.
Supports Long-Term Disease Control
Suitable for long-term management under regular medical supervision.
Clinically Established Therapy
Widely prescribed for approved inflammatory conditions in appropriate patients.
Mechanism of Action
Apremilast inhibits phosphodiesterase-4 (PDE4), increasing intracellular cAMP levels. This modulates the production of inflammatory cytokines, helping restore immune balance and reduce chronic inflammation.
Off-Label Uses
Healthcare professionals may prescribe Apremilast for conditions outside its approved indications when clinically appropriate.
Expert Advice
Take the medicine exactly as prescribed.
Attend regular follow-up appointments during therapy.
Inform your healthcare provider about all medicines and supplements you are taking.
Monitor your body weight if recommended by your doctor.
Do not discontinue treatment without medical advice.
Precautions
Use only under medical supervision.
Inform your doctor if you have kidney disease or other significant medical conditions.
Consult your doctor before use during pregnancy or breastfeeding.
Dose adjustment may be required in patients with severe renal impairment.
Storage Instructions
Store below 30°C.
Keep the tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is the active ingredient in MPRILA 30 MG TABLETS?
A: Each tablet contains Apremilast 30 mg.
Q: What drug class does MPRILA 30 MG belong to?
A: MPRILA 30 MG belongs to the Phosphodiesterase-4 (PDE4) inhibitor class of medicines.
Q: Can MPRILA 30 MG be taken with food?
A: Yes. It may be taken with or without food, as directed by your healthcare professional.
Q: Is MPRILA 30 MG a prescription medicine?
A: Yes. MPRILA 30 MG TABLETS are prescription-only and should be used under the supervision of a qualified healthcare professional.
Q: How should MPRILA 30 MG TABLETS be stored?
A: Store below 30°C in the original packaging, protected from moisture and direct sunlight.
Product Tags
MPRILA 30 MG 10 TABLETS, Apremilast 30 mg Tablet, PDE4 Inhibitor, Immunomodulatory Medicine, Anti-Inflammatory Medicine, Plaque Psoriasis Medicine, Prescription Medicine, Apremilast Tablets.
